Twist Bioscience Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Twist Bioscience Corporation (TWST) Tops Q1 EPS by 15c
February 4, 2022 7:33 AM ESTTwist Bioscience Corporation (NASDAQ: TWST) reported Q1 EPS of ($0.91), $0.15 better than the analyst estimate of ($1.06). Revenue for the quarter came in at $42 million versus the consensus estimate of $38.33 million.
GUIDANCE:
Twist Bioscience Corporation sees FY2022 revenue of $189-198 million, versus the... More



